Molecular heterogeneity in breast carcinoma cells with increased invasive capacities
, , , , , , , , , , , , , , e | 14 feb 2020
INFORMAZIONI SU QUESTO ARTICOLO
Article Category: Research Article
Pubblicato online: 14 feb 2020
Pagine: 103 - 118
Ricevuto: 10 gen 2020
Accettato: 30 gen 2020
DOI: https://doi.org/10.2478/raon-2020-0007
© 2020 Giulia Negro, Bertram Aschenbrenner, Simona Kranjc Brezar, Maja Cemazar, Andrej Coer, Gorana Gasljevic, Dragana Savic, Maxim Sorokin, Anton Buzdin, Maurizio Callari, Irma Kvitsaridze, Anahid Jewett, Mariela Vasileva-Slaveva, Ute Ganswindt, Ira Skvortsova, Sergej Skvortsov, published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Giulia Negro
Medical University of Innsbruck, Therapeutic Radiology and OncologyInnsbruck, Austria
Tyrolean Cancer Research InstituteInnsbruck, Austria
EORTC PathoBiology GroupBrussels, Belgium
Bertram Aschenbrenner
Medical University of Innsbruck, Therapeutic Radiology and OncologyInnsbruck, Austria
Tyrolean Cancer Research InstituteInnsbruck, Austria
EORTC PathoBiology GroupBrussels, Belgium
Simona Kranjc Brezar
Department of Experimental Oncology, Institute of Oncology LjubljanaLjubljana, Slovenia
Maja Cemazar
Department of Experimental Oncology, Institute of Oncology LjubljanaLjubljana, Slovenia
University of Primorska, Faculty of Health SciencesIzola, Slovenia
EORTC PathoBiology GroupBrussels, Belgium
Andrej Coer
University of Primorska, Faculty of Health SciencesIzola, Slovenia
Orthopaedic Hospital ValdoltraAnkaran, Slovenia
Gorana Gasljevic
Department of Experimental Oncology, Institute of Oncology LjubljanaLjubljana, Slovenia
Dragana Savic
Medical University of Innsbruck, Therapeutic Radiology and OncologyInnsbruck, Austria
Tyrolean Cancer Research InstituteInnsbruck, Austria
EORTC PathoBiology GroupBrussels, Belgium
Maxim Sorokin
Shemyakin-Ovchinnikov Institute of Bioorganic ChemistryMoscow, Russia
I.M. Sechenov First Moscow State Medical UniversityMoscow, Russia
Omicsway CorpWalnut, USA
EORTC PathoBiology GroupBrussels, Belgium
Anton Buzdin
Shemyakin-Ovchinnikov Institute of Bioorganic ChemistryMoscow, Russia
I.M. Sechenov First Moscow State Medical UniversityMoscow, Russia
Oncobox ltdMoscow, Russia
EORTC PathoBiology GroupBrussels, Belgium
Maurizio Callari
Cancer Research UK Cambridge Institute, University of CambridgeCambridge, UK
EORTC PathoBiology GroupBrussels, Belgium
Irma Kvitsaridze
Medical University of Innsbruck, Therapeutic Radiology and OncologyInnsbruck, Austria
Tyrolean Cancer Research InstituteInnsbruck, Austria
EORTC PathoBiology GroupBrussels, Belgium
Anahid Jewett
Division of Oral Biology and Medicine Microbiology, Immunology, & Molecular Genetics, Tumor Immunology Laboratory, College of Letters & Science, UCLA School of Dentistry and MedicineLos Angeles, USA
Mariela Vasileva-Slaveva
Medical University of Innsbruck, Therapeutic Radiology and OncologyInnsbruck, Austria
Tyrolean Cancer Research InstituteInnsbruck, Austria
EORTC PathoBiology GroupBrussels, Belgium
Ute Ganswindt
Medical University of Innsbruck, Therapeutic Radiology and OncologyInnsbruck, Austria
Ira Skvortsova
Medical University of Innsbruck, Therapeutic Radiology and OncologyInnsbruck, Austria
Tyrolean Cancer Research InstituteInnsbruck, Austria
EORTC PathoBiology GroupBrussels, Belgium
Sergej Skvortsov
Medical University of Innsbruck, Therapeutic Radiology and OncologyInnsbruck, Austria
Tyrolean Cancer Research InstituteInnsbruck, Austria